Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

CSafe eleva el transporte de terapia celular y génica con una solución criogénica reutilizable
  • BRAZIL - Portuguese
  • Korea - 한국어
  • USA - Français
  • APAC - Traditional Chinese
  • India - English
  • MEXICO - Spanish
  • USA - Deutsch
  • USA - English

CSafe

News provided by

CSafe

Apr 16, 2024, 15:04 ET

Share this article

Share toX

Share this article

Share toX

MONROE, Ohio, 16 de abril de 2024 /PRNewswire/ -- CSafe, un proveedor de soluciones de envío con temperatura controlada activa y pasiva para la industria biofarmacéutica, anuncia con orgullo el lanzamiento de una nueva línea de dewars criogénicos de usos múltiples para el mercado de terapia celular y génica. La tecnología progresiva, que es la primera de la serie CGT Cryo de CSafe, mantiene temperaturas por debajo de -150 °C.

Continue Reading
CSafe CGT Cryo M dewar and case with TracSafe RLT data logger.
CSafe CGT Cryo M dewar and case with TracSafe RLT data logger.

Los Dewars reutilizables y las cajas de envío resistentes a altos impactos están diseñados para transportar de forma segura terapias celulares y genéticas críticas, incluidos materiales biológicos precongelados, medicina regenerativa, inmunoterapias, células madre y células CAR-T.

"La industria de la terapia celular y génica necesita más soluciones que integren datos con productos, junto con una red global con capacidades avanzadas e infraestructura de servicios", afirmó Patrick Schafer, consejero delegado de CSafe. "Nuestro equipo ha trabajado incansablemente para desarrollar estas nuevas soluciones para garantizar la integridad de la valiosa carga de nuestros clientes y, en última instancia, proporcionar tranquilidad".

Estas soluciones de vanguardia ofrecen una gran variedad de características clave diseñadas para cumplir con los estrictos estándares de la industria. Preacondicionadas utilizando nitrógeno líquido, estas unidades de vapor seco cuentan con un impresionante tiempo de retención de más de 10 días frente al perfil térmico ISTA 7D, lo que proporciona altos niveles de fiabilidad para envíos críticos. Incluyen dispositivos de seguimiento de datos en tiempo real TracSafe RLT integrados para controlar la temperatura interna del producto, la temperatura ambiente externa, los golpes, la inclinación y la ubicación durante todo el viaje del envío. A través de CSafe Connect, el portal digital de la compañía, los clientes pueden rastrear fácilmente su pedido, acceder a datos en tiempo real y actualizar al servicio premium de monitoreo de envíos Control Tower para mayor seguimiento y control.

Además, los dewars multiusos proporcionan protección adicional con sellos de seguridad y un estuche de envío con cerradura para evitar manipulaciones durante el tránsito. La unidad de vapor seco cumple con la Regulación de Mercancías Peligrosas de la IATA y la tapa abovedada de la caja de envío evita el apilamiento para garantizar una orientación estable y vertical durante el tránsito y la manipulación. Cualificadas según los estándares de la industria, incluidos ISTA 3A para distribución e ISTA 7D para calificación térmica, estas soluciones de alto rendimiento ofrecen tranquilidad a los clientes.

"Nuestra nueva línea de Dewars no es sólo un producto, es una promesa", afirmó Emilio Frattaruolo, vicepresidente de terapias celulares y genéticas. "Una promesa de precisión y fiabilidad a medida que nos aventuramos hacia la próxima frontera de la innovación en terapias celulares y genéticas".

Los dewars multiusos de CSafe están actualmente disponibles en todo el mundo, en dos tamaños: 4 litros y 10 litros de capacidad.

Contacto para medios:
Emma Lupp
Vicepresidenta de Marketing Global
Directo: (41) 44-797-61-25
Email: [email protected]
Web: csafeglobal.com

Acerca de CSafe
CSafe ofrece un conjunto completo de soluciones de envío térmico para las necesidades de envío de cadena de frío de productos farmacéuticos en todo el mundo. Con un enfoque de "primero el paciente", una profunda experiencia en la industria y un compromiso con la innovación, CSafe ofrece productos tanto en el segmento activo como en el pasivo. La cartera integral de CSafe incluye carga aérea a granel activa y pasiva, paquetes, células y genes, y casos de uso especializados de última milla, que cumplen con una variedad de requisitos de envío de cadena de frío farmacéutico con calidad y fiabilidad. Ofreciendo casi cualquier tamaño, duración y temperatura: CSafe está en el corazón de su cadena de frío. csafeglobal.com

Foto - https://mma.prnewswire.com/media/2388446/RJW_150324_0526_CSafe.jpg
Logo - https://mma.prnewswire.com/media/1917781/CSafe_Logo_New.jpg 

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Also from this source

Niall Prendiville rejoint CSafe en tant que Chief Product Officer pour soutenir une croissance continue de l'innovation dans l'ensemble du portefeuille de produits

Niall Prendiville rejoint CSafe en tant que Chief Product Officer pour soutenir une croissance continue de l'innovation dans l'ensemble du portefeuille de produits

CSafe, le chef de file des solutions actives et passives de transport à température contrôlée pour l'industrie des sciences de la vie, annonce...

Niall Prendiville wird Produktvorstand bei CSafe, um das kontinuierliche Wachstum im Bereich Innovation für das gesamte Produktportfolio voranzutreiben

Niall Prendiville wird Produktvorstand bei CSafe, um das kontinuierliche Wachstum im Bereich Innovation für das gesamte Produktportfolio voranzutreiben

CSafe, ein führender Anbieter von aktiven und passiven temperaturkontrollierten Versandlösungen für die Life-Science-Branche, gab heute bekannt, dass ...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Computer & Electronics

Computer & Electronics

Medical Pharmaceuticals

Medical Pharmaceuticals

Biotechnology

Biotechnology

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.